Company Filing History:
2 out of 67 
1 out of 75 
1 out of 28 
Years Active: 2008-2009
Title: Mark Stuart Johnson: Innovator in Therapeutic Compounds
Introduction
Mark Stuart Johnson is a notable inventor based in Turku, Finland. He has made significant contributions to the field of therapeutic compounds, holding a total of three patents. His work focuses on innovative solutions for treating steroid hormone-dependent diseases and disorders.
Latest Patents
Johnson's latest patents include "Compounds and their use in therapy," which details thiophenepyrimidinone compounds aimed at treating and preventing steroid hormone-dependent diseases. This invention specifically addresses the inhibition of 17β-hydroxysteroid dehydrogenase enzymes. Another significant patent is "Crystalline VAP-1 and uses thereof," which relates to crystalline vascular adhesion protein-1 (VAP-1). This patent outlines methods for utilizing structural information of crystalline human VAP-1 for the identification, design, and production of ligands and inhibitors, as well as screening assays for their detection.
Career Highlights
Throughout his career, Johnson has worked with prominent companies such as Solvay Pharmaceuticals, B.V. and Solvay Pharmaceuticals, GmbH. His experience in these organizations has contributed to his expertise in the pharmaceutical industry and the development of innovative therapeutic solutions.
Collaborations
Johnson has collaborated with notable colleagues, including Tiina Annamaria Salminen and Leena Hirvelae. These partnerships have likely enhanced his research and development efforts in the field of therapeutic compounds.
Conclusion
Mark Stuart Johnson is a distinguished inventor whose work in therapeutic compounds has the potential to impact the treatment of steroid hormone-dependent diseases. His innovative patents and collaborations reflect his commitment to advancing medical science.